• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1例特发性腹膜后纤维化患者低剂量甲氨蝶呤治疗的长期随访

Long-term follow-up of low-dose methotrexate therapy in one case of idiopathic retroperitoneal fibrosis.

作者信息

Scavalli A S, Spadaro A, Riccieri V, Ricciuti G P, Taccari E, Marini M, Zoppini A

机构信息

Institute of Rheumatology, University La Sapienza, Rome, Italy.

出版信息

Clin Rheumatol. 1995 Jul;14(4):481-4. doi: 10.1007/BF02207688.

DOI:10.1007/BF02207688
PMID:7586991
Abstract

Idiopathic retroperitoneal fibrosis (RPF) is characterized by the development of a fibrotic mass surrounding the abdominal aorta and its branches, of unknown aetiology. Several immunological mechanisms can be operative in the pathogenesis of RPF. Based on this assumption we treated a patient affected by idiopathic RPF with low-dose methotrexate (MTX) therapy. To our knowledge this is the first example of the effectiveness and safety of a long-term low-dose MTX treatment in the post-surgical management of RPF.

摘要

特发性腹膜后纤维化(RPF)的特征是在腹主动脉及其分支周围形成纤维化肿块,病因不明。几种免疫机制可能在RPF的发病机制中起作用。基于这一假设,我们用低剂量甲氨蝶呤(MTX)疗法治疗了一名患有特发性RPF的患者。据我们所知,这是长期低剂量MTX治疗在RPF术后管理中有效性和安全性的首个实例。

相似文献

1
Long-term follow-up of low-dose methotrexate therapy in one case of idiopathic retroperitoneal fibrosis.1例特发性腹膜后纤维化患者低剂量甲氨蝶呤治疗的长期随访
Clin Rheumatol. 1995 Jul;14(4):481-4. doi: 10.1007/BF02207688.
2
Two-years follow-up of low-dose methotrexate and 6-methylprednisolone therapy in a patient with idiopathic retroperitoneal fibrosis.特发性腹膜后纤维化患者接受低剂量甲氨蝶呤和 6-甲基泼尼松龙治疗两年的随访结果。
Eur Rev Med Pharmacol Sci. 2012 Dec;16(15):2171-4.
3
[Idiopathic retroperitoneal fibrosis (Ormond's disease)].[特发性腹膜后纤维化(奥蒙德病)]
Aktuelle Urol. 2006 Jul;37(4):284-8. doi: 10.1055/s-2005-915618.
4
Efficacy of infliximab in a patient with refractory idiopathic retroperitoneal fibrosis.英夫利昔单抗治疗难治性特发性腹膜后纤维化的疗效。
Clin Exp Rheumatol. 2012 Sep-Oct;30(5):776-8. Epub 2012 Oct 17.
5
Clinical and radiological evolution of a case of idiopathic retroperitoneal fibrosis treated with Tamoxifen.
Scand J Urol Nephrol. 2002;36(5):391-2. doi: 10.1080/003655902320783953.
6
[Idiopathic retroperitoneal fibrosis--the Ormond's disease].[特发性腹膜后纤维化——奥蒙德病]
Wiad Lek. 2006;59(3-4):277-9.
7
Idiopathic retroperitoneal fibrosis in a patient suspected of impending rupture of the abdominal aortic aneurysm.疑似腹主动脉瘤即将破裂患者的特发性腹膜后纤维化
Ann Thorac Cardiovasc Surg. 2008 Feb;14(1):55-9.
8
Association between familial mediterranean fever and retroperitoneal fibrosis: retroperitoneal fibrosis regression after colchicine therapy.家族性地中海热与腹膜后纤维化之间的关联:秋水仙碱治疗后腹膜后纤维化消退
Int J Immunopathol Pharmacol. 2009 Apr-Jun;22(2):521-4. doi: 10.1177/039463200902200229.
9
Methotrexate plus prednisone in patients with relapsing idiopathic retroperitoneal fibrosis.甲氨蝶呤联合泼尼松治疗复发性特发性腹膜后纤维化患者。
Ann Rheum Dis. 2013 Sep 1;72(9):1584-6. doi: 10.1136/annrheumdis-2013-203267. Epub 2013 May 21.
10
[Chronic periaortitis].
Ann Ital Chir. 1998 Sep-Oct;69(5):601-11.

引用本文的文献

1
Into Clinical Practice: Diagnosis and Therapy of Retroperitoneal Fibrosis.进入临床实践:腹膜后纤维化的诊断与治疗。
Curr Rheumatol Rep. 2021 Feb 10;23(3):18. doi: 10.1007/s11926-020-00966-9.
2
Idiopathic retroperitoneal fibrosis and its overlap with IgG4-related disease.特发性腹膜后纤维化及其与IgG4相关疾病的重叠
Intern Emerg Med. 2017 Apr;12(3):287-299. doi: 10.1007/s11739-016-1599-z. Epub 2017 Jan 9.
3
Retroperitoneal fibrosis - the state-of-the-art.腹膜后纤维化——最新进展

本文引用的文献

1
Value of various treatments for retroperitoneal fibrosis.各种治疗方法对腹膜后纤维化的价值。
Eur Urol. 1981;7(4):193-200. doi: 10.1159/000473218.
2
The association of retroperitoneal fibrosis with systemic vasculitis and HLA-B27: a case report and review of the literature.
J Rheumatol. 1981 Jul-Aug;8(4):665-9.
3
Retroperitoneal fibrosis and polyarteritis nodosa successfully treated by intensive immunosuppression.强化免疫抑制成功治疗腹膜后纤维化和结节性多动脉炎。
J R Soc Med. 1980 Jan;73(1):61-4. doi: 10.1177/014107688007300115.
Reumatologia. 2016;54(5):256-263. doi: 10.5114/reum.2016.63667. Epub 2016 Nov 28.
4
Isolated periaortitis: clinical and imaging characteristics.孤立性主动脉周炎:临床及影像学特征
Vasc Health Risk Manag. 2007;3(6):1083-6.
5
Mycophenolate mofetil in the treatment of retroperitoneal fibrosis.
Clin Rheumatol. 2008 May;27(5):679-81. doi: 10.1007/s10067-007-0826-4. Epub 2008 Jan 8.
6
Immunosuppressive treatment of chronic periaortitis: a retrospective study of 20 patients with chronic periaortitis and a review of the literature.慢性主动脉周炎的免疫抑制治疗:20例慢性主动脉周炎患者的回顾性研究及文献综述
Ann Rheum Dis. 2005 Jun;64(6):828-33. doi: 10.1136/ard.2004.029793.
4
The combined surgical and medical treatment of retroperitoneal fibrosis.
Br J Surg. 1971 Jun;58(6):422-7. doi: 10.1002/bjs.1800580606.
5
Azathioprine. An alternative treatment for recurrent idiopathic retroperitoneal fibrosis.硫唑嘌呤。复发性特发性腹膜后纤维化的一种替代治疗方法。
Arch Intern Med. 1985 Apr;145(4):753-5. doi: 10.1001/archinte.145.4.753.
6
Idiopathic retroperitoneal fibrosis. A retrospective analysis of 60 cases.特发性腹膜后纤维化。60例回顾性分析。
Br J Urol. 1987 Dec;60(6):497-503. doi: 10.1111/j.1464-410x.1987.tb05028.x.
7
Antiproliferative effects of methotrexate on peripheral blood mononuclear cells.甲氨蝶呤对外周血单个核细胞的抗增殖作用。
Arthritis Rheum. 1989 Apr;32(4):378-85. doi: 10.1002/anr.1780320404.
8
The effects of methotrexate on the production and activity of interleukin-1.
Arthritis Rheum. 1989 Apr;32(4):370-7. doi: 10.1002/anr.1780320403.
9
Retroperitoneal fibrosis. A report of selected cases and a review of the literature.
N Y State J Med. 1989 Sep;89(9):511-6.
10
Retroperitoneal fibrosis.
Urol Radiol. 1990;12(3):135-7. doi: 10.1007/BF02923990.